Search Within

Miguel-Angel Perales

Formats
  1. Meeting Abstract (498)
  2. Journal Article (361)
  3. Review (29)
  4. Research Letter (18)
  5. Guidelines (12)
  6. Book Section (10)
  7. Correspondence (5)
  8. Editorial (5)
  9. Book Whole (1)
  10. Miscellaneous (1)
Groups
  1. Bone Marrow Transplant (940)
  2. Center for Hematologic Malignancies (940)
  3. Department of Medicine (940)
  4. Hematologic Malignancies, Division of (940)
  5. Survivorship Research (473)
  6. CTCR Scholars (410)

More Groups

People
  1. Sergio Giralt (428)
  2. Sean Devlin (302)
  3. Ann Jakubowski (247)
  4. Esperanza Papadopoulos (237)
  5. Gunjan Shah (203)
  6. Molly Maloy (196)

More People

Years
  1. 2025 (28)
  2. 2024 (76)
  3. 2023 (101)
  4. 2022 (95)
  5. 2021 (68)
  6. 2020 (93)

More Years

Publications
  1. Blood (263)
  2. Biology of Blood and Marrow Transplantation (220)
  3. Bone Marrow Transplantation (86)
  4. Transplantation and Cellular Therapy (68)
  5. Blood Advances (46)
  6. Journal of Clinical Oncology (32)

More Publications

Publishers
  1. American Society of Hematology (311)
  2. Elsevier Inc. (302)
  3. Nature Publishing Group (112)
  4. American Society of Clinical Oncology (32)
  5. Oxford University Press (18)
  6. John Wiley & Sons (17)

More Publishers

Results (940)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Barriers to immune effector cell therapy: Rapid disease progression, concern for toxicity, and lack of appropriate trials drive non-receipt after referral at a large academic center
    Meeting Abstract

    Valtis, Y. K.; Chin, K. K.; Yisraeli Salman, M.; Boussi, L.; Cadzin, B.; McLoughlin, C.; Cathcart, E.; Davis, P.; Brooklyn, C.; Goldstein, T.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Phase II study of longitudinal geriatric assessment with risk-adapted interventions to reduce non-relapse mortality in allogeneic hematopoietic cell transplantation for older patients with advanced myeloid malignancies
    Meeting Abstract

    Lin, R. J.; Kim, S. J.; Brown, S.; Hanley, D. M.; Engstler, D. E.; Politikos, I.; Gyurkocza, B.; Tamari, R.; Papadopoulos, E. B.; Saldia, A.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Long-term follow up of a prospective pilot study of an α/β T-lymphocyte depleted graft conditioned with a reduced intensity regimen in patients with hematologic malignancies
    Meeting Abstract

    Hughes, C. F. M.; Lin, R. J.; Devlin, S. M.; Shaffer, B. C.; Jakubowski, A. A.; Talla, V.; Saldia, A.; Gyurkocza, B.; Papadopoulos, E. B.; Giralt, S. A.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • A CD33-deleted allograft (trem-cel) enables post-hematopoietic cell transplant (HCT) maintenance dosing of gemtuzumab ozogamicin (GO) with therapeutic levels of drug exposure and low hematologic and hepatic toxicity in patients with high-risk acute myeloid leukemia (AML)
    Meeting Abstract

    DiPersio, J. F.; Koehne, G.; Shah, N. N.; Bernard, L.; Suh, H. C.; Koura, D.; Perales, M. A.; Tamari, R.; Mushtaq, M. U.; Maakaron, J. E.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Interim results from a phase 2 pivotal study (DALY II USA) of tandem CD20-CD19-directed non-cryopreserved CAR-T cells - Zamtocabtagene autoleucel (Zamto-Cel) in patients with relapsed/refractory diffuse large B cell lymphoma
    Meeting Abstract

    Shah, N. N.; Maziarz, R. T.; Jacobson, C. A.; Johnston, P. B.; Abhyankar, S.; Isufi, I.; Perales, M. A.; Ghosh, M.; Ulrickson, M.; Rosenthal, A. C.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Tumor determinants of response to CAR-T therapy in relapsed or refractory mantle cell lymphoma
    Meeting Abstract

    Epstein-Peterson, Z. D.; Ryan, C. E.; Devlin, S. M.; Accav, N. G.; Avigdor, A.; Corona, M.; Danylesko, I.; Dela Cruz, J.; Goy, A.; Jacobson, C. A.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • GVHD therapy with ruxolitinib is frequently associated with cytopenias, but significant decline in hemoglobin level was only observed in non-responders at day 28
    Meeting Abstract

    Gergoudis, S.; Devlin, S. M.; Susman, P.; Singh, A.; Chinapen, S.; Perales, M. A.; Ponce, D. M.
    Blood (2024)

    Fulltext@MSK | Save
  • Efficacy of budesonide monotherapy for low grade GI GVHD after post transplant cyclophosphamide
    Meeting Abstract

    Cook, M.; Vadakkel, G.; Chinapen, S.; Perales, M. A.; Tamari, R.; Papadopoulos, E. B.; Ponce, D. M.; Shaffer, B. C.; Lin, A.
    Blood (2024)

    Fulltext@MSK | Save
  • Dietary sucrose exacerbates antibiotic-induced microbiome injury in allo-HCT
    Meeting Abstract

    Rangesa, M.; Dai, A.; Adintori, P.; Jogia, W.; Fei, T.; Waters, N.; Baichoo, M.; Ballweg, A.; Sahu, S.; Schluter, J.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Real-world (RW) outcomes for brexucabtagene autoleucel (Brexu-Cel) treatment in patients (Pts) with relapsed or refractory B-cell acute lymphoblastic leukemia (R/R B-ALL) by high-risk features and prior treatments: Updated evidence from the CIBMTR® registry
    Meeting Abstract

    Wudhikarn, K.; Bezerra, E.; Yang, Y.; Perales, M. A.; Jain, N.; Gergis, U.; Aribi, A.; Hill, L.; Leonard, J. T.; Lutfi, F.; more...
    Blood (2024)

    Fulltext@MSK | Save